Depression as a risk factor for osteoporosis independent of sarcopenia in hemodialysis patients: findings from a multicenter cross-sectional study

Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD pat...

Full description

Saved in:
Bibliographic Details
Published inBMC nephrology Vol. 26; no. 1; pp. 35 - 11
Main Authors Hu, Xiaohua, Ye, Xianwu, Chen, Haimin, Wu, Bibo, Guo, Qi, Yu, Chen, Ding, Wei, Niu, Jianying, Zhao, Junli, Qi, Hualin, Zhang, Suhua, Xue, Cheng, Zhang, Liming
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 23.01.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020). In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.
AbstractList Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020). In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.
Abstract Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. Methods In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Results Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494–0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963–1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060–1.989, P = 0.020). Conclusions In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.
BackgroundOsteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.MethodsIn this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).ResultsAmong the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494–0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963–1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060–1.989, P = 0.020).ConclusionsIn HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.
Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.BACKGROUNDOsteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).METHODSIn this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9).Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020).RESULTSAmong the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020).In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.CONCLUSIONSIn HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.
Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020). In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health.
Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients. Methods In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry. Skeletal muscle mass index (SMI) was calculated from body composition data obtained through multifrequency bioimpedance analysis (BIA), while handgrip strength (HGS) was measured with a dynamometer. Gait speed was evaluated with a 4-meter walk test, and depression was assessed using the Patient Health Questionnaire-9 (PHQ-9). Results Among the 858 participants (524 men, 334 women), 39.2% had osteoporosis. The prevalence of sarcopenia and depression was 18.9% and 42.1%, respectively. Logistic regression analysis showed that SMI was significantly associated with a decreased risk of osteoporosis (OR = 0.638, 95% CI = 0.494-0.823, P = 0.001), while HGS was not(OR = 0.990, 95% CI = 0.963-1.017, P = 0.449). HD patients with sarcopenia were 1.92 times more likely to have osteoporosis than those without sarcopenia. Most notably, after adjusting for both sarcopenia and SMI, the risk of osteoporosis in HD patients with depression was 1.45 times higher than in those without depression (OR = 1.452, 95% CI = 1.060-1.989, P = 0.020). Conclusions In HD patients, increased muscle mass, rather than muscle strength, is linked to a lower risk of osteoporosis. Notably, depression emerges as a significant risk factor for osteoporosis in this population, highlighting the need for mental health considerations in managing bone health. Keywords: Sarcopenia, Depression, Osteoporosis, Hemodialysis, Bone mineral density
ArticleNumber 35
Audience Academic
Author Yu, Chen
Chen, Haimin
Qi, Hualin
Niu, Jianying
Wu, Bibo
Zhang, Liming
Hu, Xiaohua
Zhao, Junli
Zhang, Suhua
Xue, Cheng
Ding, Wei
Ye, Xianwu
Guo, Qi
Author_xml – sequence: 1
  givenname: Xiaohua
  surname: Hu
  fullname: Hu, Xiaohua
– sequence: 2
  givenname: Xianwu
  surname: Ye
  fullname: Ye, Xianwu
– sequence: 3
  givenname: Haimin
  surname: Chen
  fullname: Chen, Haimin
– sequence: 4
  givenname: Bibo
  surname: Wu
  fullname: Wu, Bibo
– sequence: 5
  givenname: Qi
  surname: Guo
  fullname: Guo, Qi
– sequence: 6
  givenname: Chen
  surname: Yu
  fullname: Yu, Chen
– sequence: 7
  givenname: Wei
  surname: Ding
  fullname: Ding, Wei
– sequence: 8
  givenname: Jianying
  surname: Niu
  fullname: Niu, Jianying
– sequence: 9
  givenname: Junli
  surname: Zhao
  fullname: Zhao, Junli
– sequence: 10
  givenname: Hualin
  surname: Qi
  fullname: Qi, Hualin
– sequence: 11
  givenname: Suhua
  surname: Zhang
  fullname: Zhang, Suhua
– sequence: 12
  givenname: Cheng
  surname: Xue
  fullname: Xue, Cheng
– sequence: 13
  givenname: Liming
  surname: Zhang
  fullname: Zhang, Liming
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39849392$$D View this record in MEDLINE/PubMed
BookMark eNptkstu1TAQhiNURC_wAiyQJTZsUnyJY4cNqsqtUiU2sLYce3LqQxIHO6nU1-CJmZxTSg9CUW6eb_7JH_-nxdEYRyiKl4yeM6brt5lxrXlJuSypaGpRsifFCasUK7mom6NHz8fFac5bSpnSFX1WHItGV41o-Enx6wNMCXIOcSQ2E0tSyD9IZ90cE-nwjHmGOMUUc8gkjB4mwMs4k9iRbJOL-B4sVsgNDNEH29-t5GTngFR-RzpsCuMmky7FAQcMSz8HhzVIxKFsLjO4GefbnuR58XfPi6ed7TO8uL-fFd8_ffx2-aW8_vr56vLiunSSybkUthK68kIq4VpHfd065bTgdcM1562HxoNopXOcS8mUk02lWds6L4USHQVxVlztdX20WzOlMNh0Z6INZrcQ08bYhJ_ag5G6xhYcB1JVDOda2UJjuaYcfFdXqPV-rzUt7QB-tZdsfyB6WBnDjdnEW8OYklJrgQpv7hVS_LlAns0QsoO-tyPEJRvB0IBAfyv6-h90G5eE_2-lajTbKKr-UhuLDsLYRRzsVlFzoXlVN4rTGqnz_1B4eBiCw7x1AdcPGl49dvpg8U-kEOB7YLe5CboHhFGz5tbsc2swt2aXW8PEb13K4UA
Cites_doi 10.1093/ndt/gfaa192
10.1038/s41430-019-0468-z
10.1016/j.clnu.2020.07.025
10.1097/MNH.0000000000000318
10.3389/fendo.2023.1181139
10.1007/s00774-017-0895-7
10.1007/s11255-017-1738-0
10.1016/j.bone.2015.04.016
10.1016/j.heliyon.2023.e19383
10.1016/j.bone.2010.01.382
10.1016/j.jamda.2013.11.025
10.1002/jcsm.12890
10.1016/S1043-2760(01)00407-6
10.1016/j.tem.2009.05.003
10.1016/j.afos.2021.04.001
10.2215/CJN.10261013
10.1186/s42358-020-0118-0
10.1007/s11255-015-0977-1
10.4103/sja.SJA_543_18
10.1046/j.1525-1497.2001.016009606.x
10.3390/nu13010147
10.3389/fmed.2020.00187
10.1001/jama.285.6.785
10.1007/s10157-022-02308-8
10.1007/s40620-020-00840-y
10.1016/j.nut.2019.02.013
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: 2025. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12882-025-03963-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Publicly Available Content Database
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Statistics
EISSN 1471-2369
EndPage 11
ExternalDocumentID oai_doaj_org_article_5863f0384e5741438a5be9a2802edf64
PMC11755883
A824697206
39849392
10_1186_s12882_025_03963_1
Genre Multicenter Study
Journal Article
GeographicLocations China
Japan
GeographicLocations_xml – name: China
– name: Japan
GrantInformation_xml – fundername: Shanghai Jing'an District Health Commission Research Project
  grantid: 2022MS04
– fundername: Shanghai science and technology innovation action plan of scientific instruments and chemical reagents project
  grantid: 24142201800
GroupedDBID ---
0R~
23N
2WC
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7QP
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c515t-3a4384d3573cbc0d6bc7c832692822bde9de3b5cc225517c59481bbcd5373f0e3
IEDL.DBID M48
ISSN 1471-2369
IngestDate Wed Aug 27 01:25:57 EDT 2025
Thu Aug 21 18:40:58 EDT 2025
Fri Jul 11 09:31:45 EDT 2025
Fri Jul 25 22:13:33 EDT 2025
Tue Jun 17 21:55:56 EDT 2025
Tue Jun 10 20:55:18 EDT 2025
Fri Aug 01 03:41:37 EDT 2025
Tue Jul 01 02:25:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Osteoporosis
Sarcopenia
Depression
Bone mineral density
Hemodialysis
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-3a4384d3573cbc0d6bc7c832692822bde9de3b5cc225517c59481bbcd5373f0e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/5863f0384e5741438a5be9a2802edf64
PMID 39849392
PQID 3165519707
PQPubID 44769
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_5863f0384e5741438a5be9a2802edf64
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11755883
proquest_miscellaneous_3159438323
proquest_journals_3165519707
gale_infotracmisc_A824697206
gale_infotracacademiconefile_A824697206
pubmed_primary_39849392
crossref_primary_10_1186_s12882_025_03963_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-01-23
PublicationDateYYYYMMDD 2025-01-23
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-23
  day: 23
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC nephrology
PublicationTitleAlternate BMC Nephrol
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References H Lee (3963_CR9) 2020; 29
S Cuschieri (3963_CR19) 2019; 13
R Matsuzawa (3963_CR7) 2021; 40
G Cizza (3963_CR29) 2001; 12
A Sabatino (3963_CR8) 2021; 34
K Ito (3963_CR14) 2020; 7
X Shu (3963_CR27) 2022; 13
N Isoyama (3963_CR5) 2014; 9
P Evenepoel (3963_CR4) 2021; 36
D Prevention (3963_CR2) 2001; 285
T Xiang (3963_CR10) 2023; 14
D Karasik (3963_CR25) 2010; 46
M Ozawa (3963_CR12) 2023; 27
LK Chen (3963_CR20) 2014; 15
L Amiri (3963_CR22) 2017; 55
H Tominaga (3963_CR15) 2018; 27
Y Li (3963_CR16) 2023; 9
K Kroenke (3963_CR21) 2001; 16
SC Chen (3963_CR13) 2019; 65
F Al Zaben (3963_CR28) 2015; 47
M Slouma (3963_CR3) 2020; 60
G Cizza (3963_CR18) 2009; 20
MZC da Silva (3963_CR6) 2019; 73
G Gerogianni (3963_CR17) 2018; 50
T Tachiki (3963_CR11) 2019; 37
3963_CR26
R Abdala (3963_CR30) 2021; 7
3963_CR23
MH Edwards (3963_CR24) 2015; 80
S Tanaka (3963_CR1) 2015; 25
References_xml – volume: 36
  start-page: 42
  issue: 1
  year: 2021
  ident: 3963_CR4
  publication-title: Nephrol Dial Transpl
  doi: 10.1093/ndt/gfaa192
– volume: 73
  start-page: 1209
  issue: 8
  year: 2019
  ident: 3963_CR6
  publication-title: Eur J Clin Nutr
  doi: 10.1038/s41430-019-0468-z
– volume: 40
  start-page: 1161
  issue: 3
  year: 2021
  ident: 3963_CR7
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2020.07.025
– ident: 3963_CR23
  doi: 10.1097/MNH.0000000000000318
– volume: 25
  start-page: 1057
  issue: 7
  year: 2015
  ident: 3963_CR1
  publication-title: Clin Calcium
– volume: 14
  start-page: 1181139
  year: 2023
  ident: 3963_CR10
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2023.1181139
– volume: 37
  start-page: 53
  issue: 1
  year: 2019
  ident: 3963_CR11
  publication-title: J Bone Min Metab
  doi: 10.1007/s00774-017-0895-7
– volume: 50
  start-page: 143
  issue: 1
  year: 2018
  ident: 3963_CR17
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-017-1738-0
– volume: 55
  start-page: 92
  issue: 2
  year: 2017
  ident: 3963_CR22
  publication-title: Acta Med Iran
– volume: 80
  start-page: 126
  year: 2015
  ident: 3963_CR24
  publication-title: Bone
  doi: 10.1016/j.bone.2015.04.016
– volume: 9
  start-page: e19383
  issue: 9
  year: 2023
  ident: 3963_CR16
  publication-title: Heliyon
  doi: 10.1016/j.heliyon.2023.e19383
– volume: 46
  start-page: 1226
  issue: 5
  year: 2010
  ident: 3963_CR25
  publication-title: Bone
  doi: 10.1016/j.bone.2010.01.382
– volume: 15
  start-page: 95
  issue: 2
  year: 2014
  ident: 3963_CR20
  publication-title: J Am Med Dir Assoc
  doi: 10.1016/j.jamda.2013.11.025
– volume: 29
  start-page: 712
  issue: 4
  year: 2020
  ident: 3963_CR9
  publication-title: Asia Pac J Clin Nutr
– volume: 13
  start-page: 145
  issue: 1
  year: 2022
  ident: 3963_CR27
  publication-title: J cachexia Sarcopenia Muscle
  doi: 10.1002/jcsm.12890
– volume: 12
  start-page: 198
  issue: 5
  year: 2001
  ident: 3963_CR29
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/S1043-2760(01)00407-6
– volume: 20
  start-page: 367
  issue: 8
  year: 2009
  ident: 3963_CR18
  publication-title: Trends Endocrinol Metab
  doi: 10.1016/j.tem.2009.05.003
– volume: 7
  start-page: 75
  issue: 2
  year: 2021
  ident: 3963_CR30
  publication-title: Osteoporos Sarcopenia
  doi: 10.1016/j.afos.2021.04.001
– volume: 9
  start-page: 1720
  issue: 10
  year: 2014
  ident: 3963_CR5
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.10261013
– volume: 60
  start-page: 15
  issue: 1
  year: 2020
  ident: 3963_CR3
  publication-title: Adv Rheumatol
  doi: 10.1186/s42358-020-0118-0
– volume: 47
  start-page: 1001
  issue: 6
  year: 2015
  ident: 3963_CR28
  publication-title: Int Urol Nephrol
  doi: 10.1007/s11255-015-0977-1
– volume: 13
  start-page: S31
  issue: Suppl 1
  year: 2019
  ident: 3963_CR19
  publication-title: Saudi J Anaesth
  doi: 10.4103/sja.SJA_543_18
– volume: 16
  start-page: 606
  issue: 9
  year: 2001
  ident: 3963_CR21
  publication-title: J Gen Intern Med
  doi: 10.1046/j.1525-1497.2001.016009606.x
– ident: 3963_CR26
  doi: 10.3390/nu13010147
– volume: 7
  start-page: 187
  year: 2020
  ident: 3963_CR14
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2020.00187
– volume: 285
  start-page: 785
  issue: 6
  year: 2001
  ident: 3963_CR2
  publication-title: JAMA
  doi: 10.1001/jama.285.6.785
– volume: 27
  start-page: 365
  issue: 4
  year: 2023
  ident: 3963_CR12
  publication-title: Clin Exp Nephrol
  doi: 10.1007/s10157-022-02308-8
– volume: 34
  start-page: 1347
  issue: 4
  year: 2021
  ident: 3963_CR8
  publication-title: J Nephrol
  doi: 10.1007/s40620-020-00840-y
– volume: 27
  start-page: 1062
  issue: 5
  year: 2018
  ident: 3963_CR15
  publication-title: Asia Pac J Clin Nutr
– volume: 65
  start-page: 6
  year: 2019
  ident: 3963_CR13
  publication-title: Nutrition
  doi: 10.1016/j.nut.2019.02.013
SSID ssj0017840
Score 2.3617845
Snippet Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental...
Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common...
BackgroundOsteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common...
Abstract Background Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 35
SubjectTerms Absorptiometry, Photon
Aged
Body composition
Bone composition
Bone Density
Bone diseases
Bone mass
Bone mineral density
Cholesterol
Chronic illnesses
Comorbidity
Complications and side effects
Cross-Sectional Studies
Depression
Depression - complications
Depression - epidemiology
Depression, Mental
Diseases
Dual energy X-ray absorptiometry
End-stage renal disease
Exercise
Female
Females
Fractures
Gait
Hand Strength
Hemodialysis
Hemodialysis patients
Humans
Investigations
Kidney diseases
Kidney Failure, Chronic - complications
Kidney Failure, Chronic - epidemiology
Kidney Failure, Chronic - psychology
Kidney Failure, Chronic - therapy
Male
Males
Malnutrition
Mental depression
Mental disorders
Mental health
Middle Aged
Mortality
Muscle strength
Osteoporosis
Osteoporosis - epidemiology
Population studies
Prevalence
Psychological aspects
Questionnaires
Regression analysis
Renal Dialysis - trends
Risk Factors
Sample size
Sarcopenia
Sarcopenia - epidemiology
Skeletal muscle
Sociodemographics
Statistics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELZQDxUXxE6gIFdC4oCsJhnbcbiVpaoqlROVerO8hb4DCWpe_0h_MTNO8vQiDly4ZhzFnsUzjme-Yex9rZIyqalEMkYJ6WQpXDRaRDx-dKFKKgb633H5XZ9fyYtrdb3X6otywiZ44IlxJ8po6EowMil0fhKMUz61rjZlnWKnMxIo-rzlMDXfHzR4bllKZIw-GXEXxkiSWreWgConqpUbymj9f-_Je05pnTC554HOHrNHc-jIT6cpP2EPUv-UHV7Ol-PP2P3XJau1527kjlPaOJ8a6nCMTTnVcwwYbw_jZuSbXf_bLR86PqLCUyetjUMKv0m_BqooIbgSPkOvjp94vuDuf46cilLwAzkbkWabbnlepxhzZhdNM-PWPmdXZ99-fDkXc8sFETCw2QpwyGEZQTUQfCij9qEJaPS6pXRTH1MbE3gVAm4DqmpCBnvxPkQFDYopwQt20A99esV4G7oaElIrB1J2pZcthC60KMkmxTIW7OMiAft7Qtaw-URitJ3kZVFeNsvLVgX7TELajSRU7PwAdcXOumL_pSsF-0AitmS7KMfg5hIEnDChYNlTU0vdNnWpC3a0Gok2F9bkRUnsbPOjhUorKgMum4Id78j0JuWx9Wm4ozHIMUCGQsFeTjq1WxIga1oMVwtmVtq2WvOa0m9uMiI44a0qY-D1_-DSG_awzpZSiRqO2MH29i69xchr699lI_sDjH0s2w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2gICMhcUBWk_gZLqg8qgqpnKi0NyuxnXYPJGW9_SP8YmYcJzRC4rrjaMeeh8f2zDeEvK1lkCboigVjJBOtKFnrjWIejh-9q4L0Du87zr6r03PxbSM3-cIt5rTK2ScmR-1Hh3fkR7xSEossS_3x6hfDrlH4uppbaNwmdxC6DFO69GY5cFUaTi9zoYxRRxF8McST2MC15KB4rFptRgmz_1_PfGNrWqdN3tiHTh6Q-zmApMeTxB-SW2F4RO6e5Sfyx-T3lzm3daBtpC3F5HE6tdWhEKFSrOoYIeoe4zbS7dIFd0_HnkZQe-yntW2BQi_DzxHrShC0hGYA1viBpmfu4SJSLE2BP0g5icht2NE0TxZTfheymdBrn5Dzk68_Pp-y3HiBOQhv9oy3ghvhudTcda70qnPagemrBpNOOx8aH3gnnQNnICvtEuRL1zkvueZ9GfhTcjCMQ3hOaOP6mgegVi0Xoi870XDXu8aIoIMvfUHezxKwVxO-hk3nEqPsJC8L8rJJXrYqyCcU0jISsbHTD-PuwmZTs9IoYAImECSESzCTVnahaWtT1sH3ShTkHYrYogWDHF2bCxGAYcTCssemFqrRdakKcrgaCZbn1uRZSWy2_Gj_6mlB3ixk_BKz2YYwXuMYWDEOC8oL8mzSqWVKHJamgaC1IGalbas5rynD9jLhgiPqqjSGv_g_Xy_JvTrZQMVqfkgO9rvr8Aoiq333OpnPH6whJVY
  priority: 102
  providerName: ProQuest
Title Depression as a risk factor for osteoporosis independent of sarcopenia in hemodialysis patients: findings from a multicenter cross-sectional study
URI https://www.ncbi.nlm.nih.gov/pubmed/39849392
https://www.proquest.com/docview/3165519707
https://www.proquest.com/docview/3159438323
https://pubmed.ncbi.nlm.nih.gov/PMC11755883
https://doaj.org/article/5863f0384e5741438a5be9a2802edf64
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9qC-KL-N3Ueqwg-CDRJPsZQeSqLeXgiqgH97Yku5v2QBN7uYL-G_7FzmySs8E--HRws3fZ-dqdzc78hpAXmfBCe5XGXmsR84InceG0jB0cPyqbeuEsvu-Yn8nTBZ8txXKHDO2OegG2Nx7tsJ_UYv3t9c_LX-_B4d8Fh9fyTQtrLMSJ2Jg1YWBQMZyG9mBnUuioc_73VkHprkASFuQ4YzIfimhu_I_RRhXw_P9dta9tW-OUymt71Mk9crcPLum0s4b7ZMfXD8jteX99_pD8_jjkvda0aGlBMbGcdi13KESvFCs-GhBG065autp2yN3QpqItuATKZlUAhV747w3WnCCgCe3BWdu3NFyB1-ctxbIVeEDIV8TZ-jUNfMZtyP3CaQZk20dkcXL89cNp3DdliC2EPpuYFZxp7phQzJY2cbK0ysKyIHNMSC2dz51npbAWFgqRKhvgYMrSOsEUqxLPHpPduqn9PqG5rTLmgZoWjPMqKXnObGVzzb3yLnEReTVowPzosDdMOLNoaTp9GdCXCfoyaUSOUEnbkYibHb5o1uemd0MjtIRJAANeQCgFnBSi9HmR6STzrpI8Ii9RxQbtDfRoi75IASaMOFlmqjMuc5UlMiKHo5HglXZMHozEDEZtWCoFFgonKiLPt2T8JWa61b65wjEgMQYCZRF50tnUliUGoskhoI2IHlnbiOcxpV5dBMxwRGQVWrOD_3jwU3InC46AXnJIdjfrK_8MQq9NOSG31FJNyN50Ovsyg8-j47NPnyfhRcYk-Nof7qMxZw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFS2EnBBvAkUMBKIA4qaxHbiICHU0lZb2l0h1Eq9uYnttHsgKZutEL_Bh_CNzHiTpRESt14z3o3H847nAfA6kU4ql8WhU0qGohBRWFiVhhbDj8rETlpD3zsm03R8LD6fyJM1-N3XwlBaZa8TvaK2jaFv5Js8TiUVWUbZx4vvIU2NotvVfoTGki0O3M8fGLK1H_Z3kL5vkmRv9-jTOOymCoQGbfci5IXgSlguM25KE9m0NJlBvk5zyqgsrcut46U0Bjldxpnx_UzK0ljJM15FjuP_3oB1wTGUGcH69u70y9fVvUWG8VJfmqPSzRa1P3qwNDI24sjqYTwwf35KwL-24IoxHCZqXrF8e3fhTueysq0lj92DNVffh5uT7lL-Afza6bNpa1a0rGCUrs6Wg3wY-sSM6kga9PObdtay2Wru7oI1FWvxRGmC16xACDt33xqqZKE2Kaxr-dq-Z_5ivT5rGRXD4At8FiTt1s2ZxzNsfUYZbdP3y30Ix9dClEcwqpvaPQGWmyrhDqFxwYWoolLk3FQmV8JlzkY2gHc9BfTFsqOH9pGQSvWSXhrppT29dBzANhFptZK6cfsHzfxMd8KtpUpxE4iAk-igISaFLF1eJCpKnK1SEcBbIrEmnYF0NEVX-oAbpu5bekslIs2zJEoD2BisRFk3Q3DPJLrTNa3-KxkBvFqB6ZeUP1e75pLW4IlxPFAewOMlT61Q4ng0ObrJAagBtw1wHkLq2bnvRE59XqVS_On_9_USbo2PJof6cH968AxuJ14e4jDhGzBazC_dc_TrFuWLTpgYnF63_P4B9YZjUQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Depression+as+a+risk+factor+for+osteoporosis+independent+of+sarcopenia+in+hemodialysis+patients%3A+findings+from+a+multicenter+cross-sectional+study&rft.jtitle=BMC+nephrology&rft.au=Hu%2C+Xiaohua&rft.au=Ye%2C+Xianwu&rft.au=Chen%2C+Haimin&rft.au=Wu%2C+Bibo&rft.date=2025-01-23&rft.issn=1471-2369&rft.eissn=1471-2369&rft.volume=26&rft.issue=1&rft.spage=35&rft_id=info:doi/10.1186%2Fs12882-025-03963-1&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon